ctrl K

Watchlist Price Alert

Hoth Therapeutics Inc. (HOTH)

NASDAQ: HOTH · Real-Time Price · USD

1.31

-0.11 (-7.75%)

At close: Jun 13, 2025, 3:59 PM

1.28

-2.29%

After-hours: Jun 13, 2025, 07:58 PM EDT

Hoth Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	66.83K	46.87M	25.87K	31.62K	28.25K	188.00
Gross Profit	n/a	n/a	-66.83K	-46.87M	-25.87K	-31.62K	-28.25K	-188
Operating Income	-8.22M	-7.69M	-11.07M	-14.1M	-7.3M	-7.71M	-2.5M	-1.87M
Interest Income	n/a	781.00	6.37K	n/a	8.00	25.00	n/a	216K
Pretax Income	-8.19M	-7.85M	-11.37M	-14.31M	-7.2M	-7.7M	-2.5M	-2.02M
Net Income	-8.19M	-7.85M	-11.68M	-14.31M	-7.2M	-7.69M	-2.5M	-2.02M
Selling & General & Admin	4.97M	4.21M	6.13M	6.57M	3.96M	5.06M	1.22M	1.28M
Research & Development	3.25M	3.48M	4.93M	7.53M	2.89M	2.12M	1.02M	586.84K
Other Expenses	n/a	n/a	451.14K	-212.26K	454.21K	538.58K	258.71K	n/a
Operating Expenses	8.22M	7.69M	11.07M	14.1M	7.3M	7.71M	2.5M	1.87M
Interest Expense	n/a	n/a	305.41K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	964.33K
Cost & Expenses	n/a	7.69M	11.07M	14.1M	7.3M	7.71M	2.5M	1.87M
Income Tax Expense	n/a	n/a	305.41K	-1.04	-205.25K	-10.36K	-159.92K	2.00
Shares Outstanding (Basic)	6.38M	3.41M	1.2M	893.2K	494.51K	366.58K	376.98K	384.48K
Shares Outstanding (Diluted)	6.38M	3.41M	1.2M	893.2K	494.51K	366.58K	376.98K	384.48K
EPS (Basic)	-1.28	-2.3	-9.75	-16.03	-14.56	-20.99	-6.62	-5.24
EPS (Diluted)	-1.28	-2.3	-9.75	-16.03	-14.56	-20.99	-6.62	-5.24
EBITDA	-8.19M	-153.15K	n/a	-14.1M	-7.3M	-7.71M	-2.49M	-2.02M
EBIT	-8.19M	-7.85M	-11.07M	-14.1M	-7.3M	-7.71M	-2.5M	-2.02M
Depreciation & Amortization	n/a	7.69M	11.07M	1.04K	1.04K	1.23K	1.22K	188.00